The reduction of IL-7 plasma levels while lymphocytopenia establishes under IFNα therapy, the absence of a correlation between IL-7 plasma levels and CD127 expression and the concomitance of decreases in IL-7 plasma levels and HCV viral load under therapy suggest that viremia might be driving IL-7 production before initiation of therapy. This evidence concerns the gene IFNA2 and lymphopenia.